A PZT-PVDF Stacked Transducer for Short-Pulse Ultrasound Therapy and Monitoring

Self-Sensing Cavitation Detection for Pulsed Cavitational Ultrasound Therapy

OBJECTIVES

Monitoring cavitation during ultrasound therapy is crucial for assessing the procedure safety and efficacy. This work aims to develop a self-sensing and low-complexity approach for robust cavitation detection in moving organs such as the heart.

METHODS

An analog-to-digital converter was connected onto one channel of the therapeutic transducer from a clinical system dedicated to cardiac therapy, allowing to record signals on a computer. Acquisition of successive echoes backscattered by the cavitation cloud on the therapeutic transducer was performed at a high repetition rate. Temporal variations of the backscattered echoes were analyzed with a Singular-Value Decomposition filter to discriminate signals associated to cavitation, based on its stochastic nature. Metrics were derived to classify the filtered backscattered echoes. Classification of raw backscattered echoes was also performed with a machine learning approach. The performances were evaluated on 155 in vitro acquisitions and 110 signals acquired in vivo during transthoracic cardiac ultrasound therapy on 3 swine.

RESULTS

Cavitation detection was achieved successfully in moving tissues with high signal to noise ratio in vitro (cSNR = 25±5) and in vivo (cSNR = 20±6) and outperformed conventional methods (cSNR = 11±6). Classification methods were validated with spectral analysis of hydrophone measurements. High accuracy was obtained using either the clutter filter-based method (accuracy of 1) or the neural network-based method (accuracy of 0.99).

CONCLUSION

Robust self-sensing cavitation detection was demonstrated to be possible with a clutter filter-based method and a machine learning approach.

SIGNIFICANCE

The self-sensing cavitation detection method enables robust, reliable and low complexity cavitation activity monitoring during ultrasound therapy.

Acoustic Stack for Combined Intravascular Ultrasound and Photoacoustic Imaging

Multimodal intravascular ultrasound and photoacoustic (IVUS/PA) imaging is a promising diagnostic tool for cardiovascular diseases like atherosclerosis. IVUS/PA catheters typically require two independent transducers due to different frequency requirements, potentially increasing the catheter size. To facilitate multimodal imaging within conventional catheter dimensions, we designed, fabricated, and characterized a dual-transducer acoustic stack where a low-frequency (LF) PA receiver sits as a matching layer for the high-frequency (HF) US transducer. While the HF transducer operates around 50 MHz, the LF receiver targets frequencies below 15 MHz to capture most of the PA energy from atherosclerotic plaque lipids. Simulation results reveal that this configuration could increase the sensitivity of the HF transducer by 3.54 dB while maintaining bandwidth. Phantom experiments with fabricated stacks showed improved performance for the US transducer, validating the enhanced sensitivity and bandwidth. Following improvements in stack fabrication, the proposed acoustic stack is a viable design that can significantly enhance diagnostic accuracy for atherosclerosis, providing high-resolution, multifrequency imaging within a compact catheter form factor.

Ultrasound transducers with both imaging and power output capabilities by anti-matching at backing layers

Precise ultrasound therapy requires long-term power output and imaging guidance. However, traditional therapeutic transducers do not have imaging capabilities due to the low bandwidth and long ringing. Whereas for a diagnostic transducer, 20%–30% of the energy is dissipated as heat in the backing layer, resulting in degradation of the transducer under high duty cycle and high voltage excitation. Therefore, the transducers with both power output and imaging capabilities are unmet demands for precise ultrasonic treatment. To address this problem, we propose an ultrasound transducer with both imaging and power output capabilities. An anti-matching layer is designed at the position of the backing layer of the transducer, which reflects the backward ultrasound waves to forward waves. Therefore, the majority of the energy is transmitted efficiently and little energy is dissipated in the backing layer. Finite element simulations demonstrated that a double-layer anti-matching design reflects 99.8% of the backward energy, resulting in an insertion loss of −27.7 dB. The performance was validated by a transducer prototype with transmission measurement using hydrophone and pulse-echo test. This design of transducers with both imaging and power output capabilities indicates a promising application of self-guided ultrasound therapy.

An Ultrasound Array of Emitter-Receiver Stacks for Microbubble-Based Therapy

Most therapeutic ultrasound devices place emitters and receivers in separate locations, so that the long therapeutic pulses (>1 ms) can be emitted while receivers monitor the procedure. However, with such placement, emitters and receivers are competing for the same space, producing a trade-off between emission efficiency and reception sensitivity. Taking advantage of recent studies demonstrating that short-pulse ultrasound can be used therapeutically, we aimed to develop a device that overcomes such trade-offs. The array was composed of emitter-receiver stacks, which enabled both emission and reception from the same location. Each element was made of a lead zirconate titanate (PZT)-polyvinylidene fluoride (PVDF) stack. The PZT (frequency: 500 kHz, diameter: 16 mm) was used for emission and the PVDF (thickness: 28 μm, diameter: 16 mm) for broadband reception. 32 elements were assembled in a 3D-printed dome-shaped frame (focal length: 150 mm; [Formula: see text]-number: 1) and was tested in free-field and through an ex-vivo human skull. In free-field, the array had a 4.5 × 4.5 × 32 mm focus and produced a peak-negative pressure (PNP) of 2.12 MPa at its geometric center. The electronic steering range was ±15 mm laterally and larger than ±15 mm axially. Through the skull, the array produced a PNP of 0.63 MPa. The PVDF elements were able to localize broadband microbubble emissions across the skull. We built the first multi-element array for short-pulse and microbubble-based therapeutic applications. Stacked arrays overcome traditional trade-offs between the transmission and reception quality and have the potential to create a step change in treatment safety and efficacy.

Highly sensitive self-focused ultrasound transducer with a bionic back-reflector for multiscale-resolution photoacoustic microscopy

In this study, we designed a self-focused ultrasonic transducer made of polyvinylidene fluoride (PVDF). This transducer involves a back-reflector, which is modeled after tapetum lucidum in the eyes of some nocturnal animals. The bionic structure reflects the ultrasound, which passes through the PVDF membrane, back to PVDF and provides a second chance for the PVDF to convert the ultrasound to electric signals. This design increases the amount of ultrasound absorbed by the PVDF, thereby improving the detection sensitivity. Both ultrasonic and photoacoustic (PA) experiments were conduct to characterize the performance of the transducer. The results show that the fabricated transducer has a center frequency of 13.07 MHz, and a bandwidth of 96% at -6 dB. With an acoustic numerical aperture (NA) of 0.64, the transducer provides a lateral resolution of 140µm. Importantly, the bionic design improves the detection sensitivity of the transducer about 30%. Finally, we apply the fabricated transducer to optical-resolution (OR) and acoustic-resolution photoacoustic microscopy (AR-PAM) to achieve multiscale-resolution PA imaging. Imaging of the bamboo leaf and the leaf skeleton demonstrates that the proposed transducer can provide high spatial resolution, better imaging intensity and contrast. Therefore, the proposed transducer design will be useful to enhance the performance of multiscale-resolution PAM.

Application of Low Temperature Processed 0-3 Composite Piezoelectric Thick Films in Flexible, Non-planar, High Frequency Ultrasonic Devices

Low-temperature, flexible, 0-3 composite piezoelectric materials can decrease the size, cost, and complexity of high-frequency acoustic devices on temperature sensitive substrates such as those in catheter based ultrasonic devices and acoustooptic sensors. In this paper, the application of low-temperature 0-3 connected composite thick films in flexible, non-planar, high frequency ultrasonic devices is reported. A flexible high-frequency ultrasound transducer and an acousto-optic radio-frequency (RF) field sensor are demonstrated utilizing PZT-based composite thick films. Flexible composite films have been fabricated with thicknesses between 20-100μm utilizing screen-printing, stencil-printing, and dip-coating techniques. Composite films' piezoelectric d33 coefficient is measured, with results between 35-43 pC/N. Ultrasonic transducers utilizing these films demonstrate broadband acoustic response. A composite transducer is fabricated on flexible polyimide and wrapped around a 3mm catheter. Pulse-echo experiments demonstrate viability of these films as both as an actuator and a sensor in flexible devices. The composite material is further dip-coated onto an optical fiber Bragg grating to form a flexible acousto-optic RF field sensor. The sensor demonstrates RF field sensing in the 20-130 MHz range. The results from these experiments indicate significant potential for future flexible, high frequency ultrasonic devices utilizing low temperature 0-3 composite piezoelectric materials on temperature sensitive substrates.

Passive Cavitation Detection With a Needle Hydrophone Array

Therapeutic ultrasound and microbubble technologies seek to drive systemically administered microbubbles into oscillations that safely manipulate tissue or release drugs. Such procedures often detect the unique acoustic emissions from microbubbles with the intention of using this feedback to control the microbubble activity. However, most sensor systems reported introduce distortions to the acoustic signal. Acoustic shockwaves, a key emission from microbubbles, are largely absent in reported recording, possibly due to the sensors being too large or too narrowband, or having strong phase distortions. Here, we built a sensor array that countered such limitations with small, broadband sensors and a low-phase distorting material. We built eight needle hydrophones with polyvinylidene fluoride (PVDF, diameter: 2 mm) then fit them into a 3-D-printed scaffold in a two-layered, staggered arrangement. Using this array, we monitored microbubbles exposed to therapeutically relevant ultrasound pulses (center frequency: 0.5 MHz, peak-rarefactional pressure: 130-597 kPa, pulselength: four cycles). Our tests revealed that the hydrophones were broadband with the best having a sensitivity of -224.8 dB ± 3.2 dB re 1 V/ μ Pa from 1 to 15 MHz. The array was able to capture shockwaves generated by microbubbles. The signal-to-noise ratio (SNR) of the array was approximately two times higher than individual hydrophones. Also, the array could localize microbubbles (-3 dB lateral resolution: 2.37 mm) and determine the cavitation threshold (between 161 and 254 kPa). Thus, the array accurately monitored and localized microbubble activities, and may be an important technological step toward better feedback control methods and safer and more effective treatments.

Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound

Brain tumors are particularly challenging malignancies, due to their location in a structurally and functionally distinct part of the human body - the central nervous system (CNS). The CNS is separated and protected by a unique system of brain and blood vessel cells which together prevent most bloodborne therapeutics from entering the brain tumor microenvironment (TME). Recently, great strides have been made through microbubble (MB) ultrasound contrast agents in conjunction with ultrasound energy to locally increase the permeability of brain vessels and modulate the brain TME. As we elaborate in this review, this physical method can effectively deliver a wide range of anticancer agents, including chemotherapeutics, antibodies, and nanoparticle drug conjugates across a range of preclinical brain tumors, including high grade glioma (glioblastoma), diffuse intrinsic pontine gliomas, and brain metastasis. Moreover, recent evidence suggests that this technology can promote the effective delivery of novel immunotherapeutic agents, including immune check-point inhibitors and chimeric antigen receptor T cells, among others. With early clinical studies demonstrating safety, and several Phase I/II trials testing the preclinical findings underway, this technology is making firm steps towards shaping the future treatments of primary and metastatic brain cancer. By elaborating on its key components, including ultrasound systems and MB technology, along with methods for closed-loop spatial and temporal control of MB activity, we highlight how this technology can be tuned to enable new, personalized treatment strategies for primary brain malignancies and brain metastases.